首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >2-Arylidene Hydrazinecarbodithioates as PotentSelective Inhibitors of Cystathionine γ-Lyase (CSE)
【2h】

2-Arylidene Hydrazinecarbodithioates as PotentSelective Inhibitors of Cystathionine γ-Lyase (CSE)

机译:2-亚丙基肼基二硫代硫酸盐有力胱硫醚γ-裂解酶(CSE)的选择性抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hydrogen sulfide is produced from l-cysteine by the action of both cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS) and increasingly has been found to play a profound regulatory role in a range of physiological processes. Mounting evidence suggests that upregulation of hydrogen sulfide biosynthesis occurs in several disease states, including rheumatoid arthritis, hypertension, ischemic injury, and sleep-disordered breathing. In addition to being critical tools in our understanding of hydrogen sulfide biology, inhibitors of CSE hold therapeutic potential for the treatment of diseases in which increased levels of this gasotransmitter play a role. We describe the discovery and development of a novel series of potent CSE inhibitors that show increased activity over the benchmark inhibitor and, importantly, display high selectivity for CSE versus CBS.
机译:硫化氢是通过胱硫醚γ-裂合酶(CSE)和胱硫醚β-合酶(CBS)的作用从l-半胱氨酸中产生的,越来越多地发现其在一系列生理过程中起着重要的调节作用。越来越多的证据表明,硫化氢生物合成的上调在几种疾病状态下发生,包括类风湿性关节炎,高血压,缺血性损伤和睡眠呼吸障碍。除了是我们了解硫化氢生物学的重要工具外,CSE抑制剂还具有治疗疾病的治疗潜力,其中这种气体递质的水平不断增加。我们描述了一系列新型的强效CSE抑制剂的发现和开发,这些抑制剂显示出比基准抑制剂更高的活性,而且重要的是,与CBS相比,CSE的选择性高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号